Education
About Us
Working with TipRanks
Follow Us
Keros Therapeutics (KROS)
NASDAQ:KROS
KROS Analyst Ratings
Moderate Buy
6 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KROS Stock 12 Month Forecast
Average Price Target
$26.43
▲( 86.65% Upside)
| Highest Price Target$35.00 | Average Price Target$26.43 | Lowest Price Target$15.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
$33
Buy
133.05%
Upside
Reiterated
05/14/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
$33
Buy
133.05%
Upside
Reiterated
05/14/25
Best Analysts Covering Keros Therapeutics
1 Month
xxx
Success Rate
13/22 ratings generated profit
Average Return
+3.95%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 59.09% of your transactions generating a profit, with an average return of +3.95% per trade.
3 Months
xxx
Success Rate
12/22 ratings generated profit
Average Return
+21.45%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 54.55% of your transactions generating a profit, with an average return of +21.45% per trade.
1 Year
Success Rate
11/22 ratings generated profit
Average Return
+5.02%
reiterated a buy rating 4 months ago
Copying Joseph Catanzaro's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +5.02% per trade.
2 Years
xxx
Success Rate
10/28 ratings generated profit
Average Return
-31.15%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 35.71% of your transactions generating a profit, with an average return of -31.15% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KROS Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
21
22
11
10
11
Buy
20
12
4
1
1
Hold
5
9
8
7
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
46
43
23
18
18
Each month's total comprises the sum of three months' worth of ratings.
KROS Financial Forecast
KROS Stock Forecast FAQ
What is KROS’s average 12-month price target, according to analysts?
Based on analyst ratings, Keros Therapeutics’s 12-month average price target is 26.43.
What is KROS’s upside potential, based on the analysts’ average price target?
Keros Therapeutics has 86.65% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KROS a Buy, Sell or Hold?
Keros Therapeutics has a consensus rating of Moderate Buy which is based on 6 buy ratings, 3 hold ratings and 0 sell ratings.
What is Keros Therapeutics’s price target?
The average price target for Keros Therapeutics is 26.43. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $15.00. The average price target represents 86.65% Increase from the current price of $14.16.
The highest analyst price target is $35.00 ,the lowest forecast is $15.00. The average price target represents 86.65% Increase from the current price of $14.16.
What do analysts say about Keros Therapeutics?
Keros Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of KROS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.